Rabbit IgG(H+L), AlpSdAbs® VHH(HRP) Alpaca Monoclonal Antibody
cat.: HA710051
| Product Type: | Alpaca monoclonal VHH domain of alpaca IgG2b/2c, secondary antibodies |
|---|---|
| Applications: | WB, ELISA |
| Clonality: | Monoclonal |
| Form: | Liquid |
| Storage condition: | Store at –20 ℃(Avoid freeze / thaw cycles), Protect from light, Stable for 12 months at -20℃ |
| Storage buffer: | 10mM PBS (pH 7.5), 0.05% sucrose, 0.1% trehalose, 0.01% proclin300, 50% Glycerol |
| Concentration: | 1ug/ul |
| Purification: | Recombinant Expression and Affinity purified |
| Isotype: | VHH domain of alpaca IgG2b/2c |
| Immunogen: | Recombinant Rabbit IgG |
| Recommended Dilutions:
ELISA WB |
1:10000-1:50000 1:10000-1:50000 Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc. The actual dilution used must be determined empirically. |
Images
|
Fig1:
Western blot analysis of Myc tag on different lysates with Rabbit anti-Myc tag antibody (HA710120) at 1/10,000 dilution. Lane 1: 293T transfected with Myc-tagged Claudin18.2 cell lysate (no heat) Lane 2: 293T transfected with Myc-tagged Histone H3.1 cell lysate Lysates/proteins at 10 µg/Lane. Exposure time: 20 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA710120) at 1/10,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Rabbit IgG(H+L), AlpSdAbs® VHH(HRP) Secondary Antibody (HA710051) at 1/10,000 dilution was used for 1 hour at room temperature. |
|
Fig2:
Advantages of using an Alpaca Recombinant Secondary 1. Smaller size Nanobodies are 1/10 the size of a traditional antibody (~15 kDa unconjugated). This means that the nanobody can penetrate tissue faster and deeper than other antibodies. 2. Easier to use Due to their simple structure, nanobodies also have the advantage of increased stability and ease of use. 3. Easier production When compared to a more traditional antibody, nanobodies are easier to develop and produce in the lab than monoclonal or polyclonal antibodies. 4. More consistent Since nanobodies are recombinantly produced from clonal DNA, you are guaranteed the same product every time. Comparatively, polyclonal antibodies are produced in live animals and have a very low lot-to-lot consistency while monoclonal antibodies can suffer from drift. 5. Higher Affinity Nanobodies benefit from consistently high binding affinity values. |
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.